• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by NeueHealth Inc.

    10/2/25 10:58:11 AM ET
    $NEUE
    Medical Specialities
    Health Care
    Get the next $NEUE alert in real time by email
    S-8 POS 1 tm2527826d4_s8pos.htm S-8 POS

     

    As filed with the Securities and Exchange Commission on October 2, 2025

     

    Registration No. 333-279463

    Registration No. 333-271987

    Registration No. 333-257477

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    POST-EFFECTIVE AMENDMENT NO. 1 TO:

    Form S-8 Registration Statement No. 333-279463

    Form S-8 Registration Statement No. 333-271987

    Form S-8 Registration Statement No. 333-257477

    UNDER

    THE SECURITIES ACT OF 1933

     

     

    NEUEHEALTH, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware 47-4991296
    (State or other jurisdiction of
    incorporation or organization)
    (I.R.S. Employer
    Identification Number)
       

    9250 NW 36th St Suite 420

    Doral, FL

    33178

    (Address of Principal Executive
    Office)

    (Zip Code)

     

    NeueHealth, Inc. Second Amended and Restated 2021 Omnibus Incentive Plan

    Bright Health Group, Inc. 2016 Stock Incentive Plan

    (Full Title of the Plans)

     

    Jeff Craig

    General Counsel and Corporate Secretary

    9250 NW 36th St Suite 420

    Doral, FL 33178

    (Name and address of agent for service)

     

    (612) 238-1321 

    (Registrant’s Telephone Number, Including Area Code)

     

    Copies to:

    Simpson Thacher & Bartlett LLP

    2475 Hanover Street

    Palo Alto, California 94304

    Email: [email protected];

    [email protected]

    Attention: Atif I. Azher; William B. Brentani

     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ¨ Accelerated filer ¨
    Non-accelerated filer x Smaller reporting company x
      Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

     

     

     

     

     

     

    DEREGISTRATION OF SECURITIES

     

    This Post-Effective Amendment No. 1 (this “Post-Effective Amendment”) relates to the following Registration Statements on Form S-8 (each, a “Registration Statement” and collectively, the “Registration Statements”) of NeueHealth, Inc., a Delaware corporation (the “Registrant”), which were previously filed by the Registrant with the U.S. Securities and Exchange Commission (the “SEC”):

     

    1.  Registration Statement on Form S-8 (File No. 333-279463), filed with the SEC on May 16, 2024, pertaining to the registration of 2,275,000 shares of common stock of the Registrant, par value $0.0001 per share (the “Common Stock”) for delivery with respect to awards under the NeueHealth, Inc. Second Amended and Restated 2021 Omnibus Incentive Plan (the “2021 Incentive Plan”).

     

    2.  Registration Statement on Form S-8 (File No. 333-271987), filed with the SEC on May 17, 2023, pertaining to the registration of 156,622,359* shares of Common Stock for delivery with respect to awards under the 2021 Incentive Plan.
       
    3. Registration Statement on Form S-8 (File No. 333-257477), filed with the SEC on June 28, 2021, pertaining to the registration of (i) 42,000,000* shares of Common Stock for delivery with respect to awards under the 2021 Incentive Plan and (ii) 72,285,567* shares of Common Stock for delivery with respect to awards under the Bright Health Group, Inc. 2016 Stock Incentive Plan.

     

    * The number of shares of Common Stock originally registered have not been adjusted to reflect the one-for-eighty (1-for-80) reverse stock split that became effective on May 19, 2023.

     

    On October 2, 2025, pursuant to the Agreement and Plan of Merger, dated December 23, 2024, by and among the Registrant, NH Holdings 2025, Inc., a Delaware corporation (“Parent”), and NH Holdings Acquisition 2025, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), Merger Sub merged with and into the Registrant (the “Merger”), with the Registrant surviving the Merger as a wholly owned subsidiary of Parent.

     

    As a result of the Merger, the Registrant is terminating all existing registration statements under the Securities Act of 1933, as amended, of the Registrant, including the Registration Statements. The Registrant hereby terminates the effectiveness of the Registration Statements and removes from registration, by means of a post-effective amendment, any and all securities of the Registrant registered for issuance under the Registration Statements that remain unissued as of the date of this Post-Effective Amendment. The Registration Statements are hereby amended, as appropriate, to reflect the deregistration of such securities.

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Doral, State of Florida, on October 2, 2025.

     

    NEUEHEALTH, INC.  
         
    By: /s/ Jeff Craig  
    Name: Jeff Craig  
    Title: General Counsel and Corporate Secretary  

     

    Pursuant to Rule 478 under the Securities Act of 1933, as amended, no other person is required to sign this Post-Effective Amendment.

     

    3

     

    Get the next $NEUE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NEUE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $NEUE
    SEC Filings

    View All

    SEC Form 15-12G filed by NeueHealth Inc.

    15-12G - NeueHealth, Inc. (0001671284) (Filer)

    10/14/25 6:02:35 AM ET
    $NEUE
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13D/A filed by NeueHealth Inc.

    SCHEDULE 13D/A - NeueHealth, Inc. (0001671284) (Subject)

    10/6/25 5:00:02 PM ET
    $NEUE
    Medical Specialities
    Health Care

    SEC Form S-8 POS filed by NeueHealth Inc.

    S-8 POS - NeueHealth, Inc. (0001671284) (Filer)

    10/2/25 11:02:08 AM ET
    $NEUE
    Medical Specialities
    Health Care

    $NEUE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NeueHealth Announces Closing of Take-Private Transaction

    NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today announced the successful closing of its previously announced merger under which NeueHealth has been acquired by an affiliate of New Enterprise Associates ("NEA") at an enterprise value of approximately $1.465 billion. Under the terms of the merger agreement, holders of NeueHealth common stock (other than shares that will be rolled over and certain excluded shares) will receive $7.33 per share in cash. Certain stockholders of NeueHeath, including NEA and 12 existing NeueHealth investors (which collectively hold all of the outstanding shares of NeueHealth preferred stock), have entered i

    10/2/25 9:16:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    NeueHealth Reports Second Quarter 2025 Results

    Delivered strong second quarter financial results, reflecting the continued success of consumer-centric care model and ability to create value for consumers, payors, and providers across the industry Drove positive Adjusted EBITDA for the sixth consecutive quarter, placing the company in a strong position to drive long-term, sustainable growth this year and beyond Served approximately 694,000 consumers, an increase of 45% over the second quarter of 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its second quarter ended June 30, 2025. "We are pleased to report another strong quarter of f

    8/7/25 6:45:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    NeueHealth to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025

    NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report second quarter financial results before the financial markets open on Thursday, August 7, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests parti

    7/17/25 8:00:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    $NEUE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Matushak Jay returned 40,431 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - NeueHealth, Inc. (0001671284) (Issuer)

    10/14/25 7:54:57 PM ET
    $NEUE
    Medical Specialities
    Health Care

    Large owner Bessemer Venture Partners Ix L.P. returned 999,218 shares to the company (SEC Form 4)

    4 - NeueHealth, Inc. (0001671284) (Issuer)

    10/6/25 7:45:32 PM ET
    $NEUE
    Medical Specialities
    Health Care

    Director Kraus Stephen returned 16,443 shares to the company, closing all direct ownership in the company (SEC Form 4)

    4 - NeueHealth, Inc. (0001671284) (Issuer)

    10/6/25 7:35:04 PM ET
    $NEUE
    Medical Specialities
    Health Care

    $NEUE
    Financials

    Live finance-specific insights

    View All

    NeueHealth Reports Second Quarter 2025 Results

    Delivered strong second quarter financial results, reflecting the continued success of consumer-centric care model and ability to create value for consumers, payors, and providers across the industry Drove positive Adjusted EBITDA for the sixth consecutive quarter, placing the company in a strong position to drive long-term, sustainable growth this year and beyond Served approximately 694,000 consumers, an increase of 45% over the second quarter of 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its second quarter ended June 30, 2025. "We are pleased to report another strong quarter of f

    8/7/25 6:45:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    NeueHealth to Host Second Quarter 2025 Earnings Conference Call on August 7, 2025

    NeueHealth, Inc. ("NeueHealth") (NYSE:NEUE), the value-driven healthcare company, today announced it will report second quarter financial results before the financial markets open on Thursday, August 7, 2025, followed by a conference call at 8:00 AM Eastern Time. To participate via telephone, please pre-register at this link. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including dial-in number, conference number, and personal code that can be used to access the call. A webcast of the earnings call may also be accessed via NeueHealth's Investor Relations page at investors.neuehealth.com. The company suggests parti

    7/17/25 8:00:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    NeueHealth Reports First Quarter 2025 Results

    Delivered strong first quarter performance as care model continues to resonate with consumers, providers, and payors across the healthcare industry Drove positive Adjusted EBITDA for the fifth consecutive quarter, providing a strong foundation for continued success in 2025 and beyond Served approximately 709,000 consumers, an increase of 51% over the first quarter of 2024 NeueHealth, Inc. ("NeueHealth" or the "Company") (NYSE:NEUE), the value-driven healthcare company, today reported financial results for its first quarter ended March 31, 2025. "We are starting 2025 in a very strong position, generating substantial growth in the number of consumers we serve and delivering another

    5/8/25 6:45:00 AM ET
    $NEUE
    Medical Specialities
    Health Care

    $NEUE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by NeueHealth Inc. (Amendment)

    SC 13D/A - NeueHealth, Inc. (0001671284) (Subject)

    4/10/24 9:52:09 PM ET
    $NEUE
    Medical Specialities
    Health Care